[HTML][HTML] Mutant copper-zinc superoxide dismutase (SOD1) induces protein secretion pathway alterations and exosome release in astrocytes: implications for disease …
…, M Tortarolo, F Fiordaliso, C Bisighini, L Pasetto… - Journal of Biological …, 2013 - ASBMB
Amyotrophic lateral sclerosis is the most common motor neuron disease and is still incurable.
The mechanisms leading to the selective motor neuron vulnerability are still not known. …
The mechanisms leading to the selective motor neuron vulnerability are still not known. …
[HTML][HTML] Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations
V Bonetto, L Pasetto, I Lisi, M Carbonara… - Frontiers in …, 2022 - frontiersin.org
Background Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection is
associated with disorders affecting the peripheral and the central nervous system. A high …
associated with disorders affecting the peripheral and the central nervous system. A high …
New insights on the mechanisms of disease course variability in ALS from mutant SOD1 mouse models
…, M Tortarolo, A Vallarola, M Freschi, L Pasetto… - Brain …, 2016 - Wiley Online Library
Amyotrophic Lateral Sclerosis (ALS) is a heterogeneous disease in terms of progression
rate and survival. This is probably one of the reasons for the failure of many clinical trials and …
rate and survival. This is probably one of the reasons for the failure of many clinical trials and …
[HTML][HTML] Role of extracellular vesicles in amyotrophic lateral sclerosis
D Ferrara, L Pasetto, V Bonetto, M Basso - Frontiers in neuroscience, 2018 - frontiersin.org
Amyotrophic Lateral Sclerosis (ALS) is the most common motor neuron disease in adults and
primarily targets upper and lower motor neurons. The progression of the disease is mostly …
primarily targets upper and lower motor neurons. The progression of the disease is mostly …
Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double‐blind, placebo‐controlled trial
…, E Bianchi, V Bonetto, S Luotti, L Pasetto… - European Journal of …, 2023 - Wiley Online Library
Background and purpose Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative
disease with limited treatment options. RNS60 is an immunomodulatory and neuroprotective …
disease with limited treatment options. RNS60 is an immunomodulatory and neuroprotective …
[HTML][HTML] Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis
L Pasetto, S Callegaro, A Corbelli, F Fiordaliso… - Molecular …, 2021 - Springer
Background Amyotrophic lateral sclerosis (ALS) is a multifactorial, multisystem motor
neuron disease for which currently there is no effective treatment. There is an urgent need to …
neuron disease for which currently there is no effective treatment. There is an urgent need to …
Targeting extracellular cyclophilin A reduces neuroinflammation and extends survival in a mouse model of amyotrophic lateral sclerosis
L Pasetto, S Pozzi, M Castelnovo, M Basso… - Journal of …, 2017 - Soc Neuroscience
Neuroinflammation is a major hallmark of amyotrophic lateral sclerosis (ALS), which is currently
untreatable. Several anti-inflammatory compounds have been evaluated in patients and …
untreatable. Several anti-inflammatory compounds have been evaluated in patients and …
Lack of TNF‐alpha receptor type 2 protects motor neurons in a cellular model of amyotrophic lateral sclerosis and in mutant SOD1 mice but does not affect disease …
…, S Garetto, E Martini, L Pasetto… - Journal of …, 2015 - Wiley Online Library
Abstract Changes in the homeostasis of tumor necrosis factor α (TNFα) have been demonstrated
in patients and experimental models of amyotrophic lateral sclerosis (ALS). However, …
in patients and experimental models of amyotrophic lateral sclerosis (ALS). However, …
[HTML][HTML] RNS60 exerts therapeutic effects in the SOD1 ALS mouse model through protective glia and peripheral nerve rescue
…, M Tortarolo, N Gatto, R De Gioia, L Pasetto… - Journal of …, 2018 - Springer
Background Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease
that affects the motor neuromuscular system leading to complete paralysis and premature …
that affects the motor neuromuscular system leading to complete paralysis and premature …
Peptidylprolyl isomerase A governs TARDBP function and assembly in heterogeneous nuclear ribonucleoprotein complexes
E Lauranzano, S Pozzi, L Pasetto, R Stucchi… - Brain, 2015 - academic.oup.com
Peptidylprolyl isomerase A (PPIA), also known as cyclophilin A, is a multifunctional protein
with peptidyl-prolyl cis-trans isomerase activity. PPIA is also a translational biomarker for …
with peptidyl-prolyl cis-trans isomerase activity. PPIA is also a translational biomarker for …
